325 related articles for article (PubMed ID: 34990001)
1. Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma.
Kadian LK; Arora M; Prasad CP; Pramanik R; Chauhan SS
Clin Transl Oncol; 2022 Jun; 24(6):1014-1032. PubMed ID: 34990001
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
[TBL] [Abstract][Full Text] [Related]
3. DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway.
Ge Y; Fan X; Huang X; Weygant N; Xiao Z; Yan R; Liu H; Liu J; An G; Yao J
Mol Cancer Res; 2021 Dec; 19(12):1980-1991. PubMed ID: 34610960
[TBL] [Abstract][Full Text] [Related]
4. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
5. WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma.
Abbaszadegan MR; Riahi A; Forghanifard MM; Moghbeli M
Cell Mol Biol Lett; 2018; 23():42. PubMed ID: 30202417
[TBL] [Abstract][Full Text] [Related]
6. Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
Wu H; Yu J; Kong D; Xu Y; Zhang Z; Shui J; Li Z; Luo H; Wang K
Int J Oncol; 2019 Dec; 55(6):1237-1248. PubMed ID: 31638164
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
8. Clinical and translational advances in esophageal squamous cell carcinoma.
Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
[TBL] [Abstract][Full Text] [Related]
9. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
10. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2.
You BH; Yoon JH; Kang H; Lee EK; Lee SK; Nam JW
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24620-24629. PubMed ID: 31732666
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
Yu X; Huang M; Yang G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
13. Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.
Umeda S; Kanda M; Koike M; Tanaka H; Miwa T; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Kodera Y
Oncol Rep; 2018 Dec; 40(6):3772-3780. PubMed ID: 30272363
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
15. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.
Zhang J; Wang JL; Zhang CY; Ma YF; Zhao R; Wang YY
Clin Transl Oncol; 2020 Jul; 22(7):1172-1179. PubMed ID: 31748958
[TBL] [Abstract][Full Text] [Related]
16. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y
Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
[TBL] [Abstract][Full Text] [Related]
19. Identification of genomic alterations in oesophageal squamous cell cancer.
Song Y; Li L; Ou Y; Gao Z; Li E; Li X; Zhang W; Wang J; Xu L; Zhou Y; Ma X; Liu L; Zhao Z; Huang X; Fan J; Dong L; Chen G; Ma L; Yang J; Chen L; He M; Li M; Zhuang X; Huang K; Qiu K; Yin G; Guo G; Feng Q; Chen P; Wu Z; Wu J; Ma L; Zhao J; Luo L; Fu M; Xu B; Chen B; Li Y; Tong T; Wang M; Liu Z; Lin D; Zhang X; Yang H; Wang J; Zhan Q
Nature; 2014 May; 509(7498):91-5. PubMed ID: 24670651
[TBL] [Abstract][Full Text] [Related]
20. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
